Sponsor or institution
Clinical trials and research at Genoss Co., Ltd.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Genoss Co., Ltd. that are recruiting, in South Korea. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| DCB-based PCI vs DES-based PCI in multivessel coronary disease | — | Ulsan | Recruiting | Apr 20, 2026 |
| Long femoropopliteal artery disease: GENOSS paclitaxel-coated balloon safety and effectiveness after PTA | — | Suwon, Gyeonggi-do | Recruiting | Feb 20, 2026 |
| Evaluating 1-year Dual Antiplatelet Therapy after GENOSS® Stent Implantation in Heart Disease Patients | — | Wŏnju, Gangwon State | Recruiting | Oct 10, 2023 |
| Evaluating short-term dual antiplatelet therapy after a specific heart stent implantation | — | Wŏnju, Gangwon State | Recruiting | Oct 10, 2023 |
| Evaluating the OSFIT drug-eluting stent for coronary artery stenosis | — | Suwon | Recruiting | Oct 4, 2023 |
All recruiting trials (5)
-
DCB-based PCI vs DES-based PCI in multivessel coronary disease
This study tests whether using a drug-coated balloon for PCI works as well as drug-eluting stents in people with disease in multiple coronary arteries.
-
Long femoropopliteal artery disease: GENOSS paclitaxel-coated balloon safety and effectiveness after PTA
This study tests whether the GENOSS paclitaxel-coated balloon is safe and helps keep the treated leg arteries open in adults with long femoropopliteal lesions after angioplasty.
-
Evaluating 1-year Dual Antiplatelet Therapy after GENOSS® Stent Implantation in Heart Disease Patients
This study is testing whether a year of dual antiplatelet therapy after getting a GENOSS® stent helps heart disease patients stay healthy and avoid serious heart problems.
-
Evaluating short-term dual antiplatelet therapy after a specific heart stent implantation
This study is testing whether a short period of dual antiplatelet therapy after getting a specific heart stent can keep patients with coronary artery disease safe and healthy over a year.
-
Evaluating the OSFIT drug-eluting stent for coronary artery stenosis
This study is testing whether the OSFIT drug-eluting stent is safe and effective for people with narrowed coronary arteries near the heart's main opening, following them for a year after their procedure.
Quick answers
How many clinical trials run by Genoss Co., Ltd. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.